Advagene Biopharma Co., Ltd.

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

16

Website

www.advagene.com.tw

Country

Taiwan

Exchange

Taipei Exchange

Founded 2006

Advagene Biopharma provides the research and development of vaccine technology and related products in Taiwan. It engages in the development of nasal spray influenza vaccine. Its portfolio also includes respiratory allergy treatment vaccine, including rhinitis and asthma, COVID-19 immunotherapy, and vaccines. Founded in 2006, the company is based in Taipei, Taiwan.

Key Stats

52-Week Range

NT$19.90NT$41.00

Beta0.62

Trailing P/EN/A

Forward P/EN/A

Trailing EPS-1.14

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.